Antibacterial responses of retinal Müller glia: Production of antimicrobial peptides, oxidative burst and phagocytosis

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Singh, Pawan K ^a   Shiha, Melissa J ^a   Kumar, Ashok ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial Peptides; M ller glia; Phagocytosis; RNS; ROS; S. aureus

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; HEPCIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; POLYPEPTIDE ANTIBIOTIC AGENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; BACTERIAL EYE INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BACTERIUM CULTURE; CELL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MUELLER CELL; NONHUMAN; PEPTIDE SYNTHESIS; PHAGOCYTOSIS; RESPIRATORY BURST; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CELL LINE, TRANSFORMED; COLONY COUNT, MICROBIAL; EPENDYMOGLIAL CELLS; GENE EXPRESSION REGULATION, BACTERIAL; HEPCIDINS; HUMANS; NITRITES; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS;

EID: 84896389865     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-33     Document Type: Article

References (52)

1. Garcia M, Vecino E. Role of Müller glia in neuroprotection and regeneration in the retina. Histology and histopathology 2003, 18:1205-1218.
2. Roesch K, Jadhav AP, Trimarchi JM, Stadler MB, Roska B, Sun BB, Cepko CL. The transcriptome of retinal Müller glial cells. The Journal of comparative neurology 2008, 509:225-238. 10.1002/cne.21730, 2665263, 18465787.
3. Newman E, Reichenbach A. The Müller cell: a functional element of the retina. Trends in neurosciences 1996, 19(2):307-312.
4. Ponsioen TL, van Luyn MJ, van der Worp RJ, Nolte IM, Hooymans JM, Los LI. In vitro phagocytosis of collagens by immortalized human retinal Müller cells. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2007, 245:82-92.
5. Kumar A, Pandey RK, Miller JL, Singh PK, Kanwar M. Müller glia in retinal innate immunity: a perspective on their roles in endophthalmitis. Crit Rev Immunol 2013, 33:119-135. 10.1615/CritRevImmunol.2013006618, 3697845, 23582059.
6. Sadaka A, Durand ML, Gilmore MS. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Progress in retinal and eye research 2012, 31:316-331. 10.1016/j.preteyeres.2012.03.004, 3361607, 22521570.
7. Diago T, McCannel CA, Bakri SJ, Pulido JS, Edwards AO, Pach JM. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 2009, 29:601-605. 10.1097/IAE.0b013e31819d2591, 19357558.
8. Klein KS, Walsh MK, Hassan TS, Halperin LS, Castellarin AA, Roth D, Driscoll S, Prenner JL. Endophthalmitis after anti-VEGF injections. Ophthalmology 2009, 116:1225-e1221. 10.1016/j.ophtha.2009.02.031, 19486799.
9. Sampat KM, Garg SJ. Complications of intravitreal injections. Current opinion in ophthalmology 2010, 21:178-183. 10.1097/ICU.0b013e328338679a, 20375895.
10. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. Journal of cataract and refractive surgery 2006, 32:407-410. 10.1016/j.jcrs.2006.02.021, 16631047.
11. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, McDonnell PJ. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Archives of Ophthalmology 2005, 123:613-620. 10.1001/archopht.123.5.613, 15883279.
12. Jonas JB, Knorr HL, Budde WM. Prognostic factors in ocular injuries caused by intraocular or retrobulbar foreign bodies. Ophthalmology 2000, 107:823-828. 10.1016/S0161-6420(00)00079-8, 10811069.
13. Thompson JT, Parver LM, Enger CL, Mieler WF, Liggett PE. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. National Eye Trauma System. Ophthalmology 1993, 100:1468-1474.
14. Thompson WS, Rubsamen PE, Flynn HW, Schiffman J, Cousins SW. Endophthalmitis after penetrating trauma. Risk factors and visual acuity outcomes. Ophthalmology 1995, 102:1696-1701. 10.1016/S0161-6420(95)30807-X, 9098264.
15. Kumar A, Shamsuddin N. Retinal Müller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS One 2012, 7:e29830. 10.1371/journal.pone.0029830, 3253788, 22253793.
16. Lenkowski JR, Raymond PA. Müller glia: stem cells for generation and regeneration of retinal neurons in teleost fish. Progress in Retinal and Eye Research 2014, http://dx.doi.org/10.1016/j.preteyeres.2013.12.007.
17. Takeda K, Akira S. Regulation of innate immune responses by Toll-like receptors. Jpn J Infect Dis 2001, 54:209-219.
18. Takeda K, Akira S. Microbial recognition by Toll-like receptors. J Dermatol Sci 2004, 34:73-82. 10.1016/j.jdermsci.2003.10.002, 15033189.
19. Kochan T, Singla A, Tosi J, Kumar A. Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infect Immun 2012, 80:2076-2088. 10.1128/IAI.00149-12, 3370599, 22431652.
20. Pandey RK, Yu FS, Kumar A. Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases. Ind J Med Res 2013, 138:609-619.
21. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003, 3:710-720. 10.1038/nri1180, 12949495.
22. Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 1997, 272:13088-13093. 10.1074/jbc.272.20.13088, 9148921.
23. Callegan MC, Gilmore MS, Gregory M, Ramadan RT, Wiskur BJ, Moyer AL, Hunt JJ, Novosad BD. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog Retin Eye Res 2007, 26:189-203. 10.1016/j.preteyeres.2006.12.001, 1941835, 17236804.
24. Otri AM, Mohammed I, Abedin A, Cao Z, Hopkinson A, Panjwani N, Dua HS. Antimicrobial peptides expression by ocular surface cells in response to Acanthamoeba castellanii: an in vitro study. The British journal of ophthalmology 2010, 94:1523-1527. 10.1136/bjo.2009.178236, 20679078.
25. Kumar A, Singh CN, Glybina IV, Mahmoud TH, Yu FS. Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. J Infect Dis 2010, 201:255-263. 10.1086/649589, 2798006, 19995266.
26. Spellberg BJ, Collins M, French SW, Edwards JE, Fu Y, Ibrahim AS. A phagocytic cell line markedly improves survival of infected neutropenic mice. Journal of leukocyte biology 2005, 78:338-344. 10.1189/jlb.0205072, 15857941.
27. Spellberg BJ, Collins M, Avanesian V, Gomez M, Edwards JE, Cogle C, Applebaum D, Fu Y, Ibrahim AS. Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Journal of leukocyte biology 2007, 81:632-641.
28. Baquir B, Lemaire S, Van Bambeke F, Tulkens PM, Lin L, Spellberg B. Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2012, 54(Suppl 3):S229-232. 10.1093/cid/cir921, 3307583, 22431853.
29. Shamsuddin N, Kumar A. TLR2 mediates the innate response of retinal Müller glia to Staphylococcus aureus. Journal of immunology 2011, 186:7089-7097.
30. Serbina NV, Pamer EG. Coordinating innate immune cells to optimize microbial killing. Immunity 2008, 29:672-674. 10.1016/j.immuni.2008.10.003, 2921660, 19006691.
31. Lehmann J, Retz M, Harder J, Krams M, Kellner U, Hartmann J, Hohgrawe K, Raffenberg U, Gerber M, Loch T, Weichert-Jacobsen K, Stöckle M. Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC infectious Diseases 2002, 2:20. 10.1186/1471-2334-2-20, 128826, 12238953.
32. Gambichler T, Skrygan M, Huyn J, Bechara FG, Sand M, Altmeyer P, Kreuter A. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. BMC cancer 2006, 6:163. 10.1186/1471-2407-6-163, 1538617, 16796735.
33. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infection and immunity 2008, 76:4176-4182. 10.1128/IAI.00318-08, 2519444, 18591225.
34. Hell E, Giske CG, Nelson A, Romling U, Marchini G. Human cathelicidin peptide LL37 inhibits both attachment capability and Biofilm formation of Staphylococcus epidermidis. Letters in applied microbiology 2010, 50:211-215. 10.1111/j.1472-765X.2009.02778.x, 20002576.
35. Zegans ME, Becker HI, Budzik J, O'Toole G. The role of bacterial biofilms in ocular infections. DNA Cell Biol 2002, 21:415-420. 10.1089/10445490260099700, 12167244.
36. Elssner A, Duncan M, Gavrilin M, Wewers MD. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. Journal of immunology 2004, 172:4987-4994.
37. Kajiya M, Shiba H, Komatsuzawa H, Ouhara K, Fujita T, Takeda K, Uchida Y, Mizuno N, Kawaguchi H, Kurihara H. The antimicrobial peptide LL37 induces the migration of human pulp cells: a possible adjunct for regenerative endodontics. Journal of endodontics 2010, 36:1009-1013. 10.1016/j.joen.2010.02.028, 20478456.
38. Ramos R, Silva JP, Rodrigues AC, Costa R, Guardao L, Schmitt F, Soares R, Vilanova M, Domingues L, Gama M. Wound healing activity of the human antimicrobial peptide LL37. Peptides 2011, 32:1469-1476. 10.1016/j.peptides.2011.06.005, 21693141.
39. Chothe PP, Gnana-Prakasam JP, Ananth S, Martin PM, Kannan R, Hinton DR, Smith SB, Ganapathy V. Transport of hepcidin, an iron-regulatory peptide hormone, into retinal pigment epithelial cells via oligopeptide transporters and its relevance to iron homeostasis. Biochemical and biophysical research communications 2011, 405:244-249. 10.1016/j.bbrc.2011.01.018, 3060409, 21219868.
40. Gnana-Prakasam JP, Martin PM, Mysona BA, Roon P, Smith SB, Ganapathy V. Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe. The Biochemical journal 2008, 411:79-88. 10.1042/BJ20071377, 3731152, 18042040.
41. Friedenwald Js CE. Pathogenesis of retinitis pigmentosa: with a note on the phagocytic activity of Müller's fibers. Archives of Ophthalmology 1932, 8:173-181.
42. Mano T, Puro DG. Phagocytosis by human retinal glial cells in culture. Investigative ophthalmology & visual science 1990, 31:1047-1055.
43. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS, Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480. 10.1038/nature09973, 3460538, 21525932.
44. Pai AB, Patel H, Prokopienko AJ, Alsaffar H, Gertzberg N, Neumann P, Punjabi A, Johnson A. Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen species. PloS one 2012, 7:e49209. 10.1371/journal.pone.0049209, 3499573, 23166614.
45. De Groote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 1995, 21(Suppl 2):S162-165.
46. Jones-Carson J, Laughlin JR, Stewart AL, Voskuil MI, Vazquez-Torres A. Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei. Nitric oxide: biology and chemistry official journal of the Nitric Oxide Society 2012, 27:25-31.
47. Ren B, Zhang N, Yang J, Ding H. Nitric oxide-induced bacteriostasis and modification of iron-sulphur proteins in Escherichia coli. Molecular microbiology 2008, 70:953-964. 2662482, 18811727.
48. De Groote MA, Granger D, Xu Y, Campbell G, Prince R, Fang FC. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:6399-6403. 10.1073/pnas.92.14.6399, 41525, 7604003.
49. Vazquez-Torres A, Jones-Carson J, Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infection and immunity 1995, 63:1142-1144. 173125, 7868241.
50. Miller RA, Britigan BE. Role of oxidants in microbial pathophysiology. Clin Microbiol Rev 1997, 10:1-18. 172912, 8993856.
51. Fletcher AE. Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration. Ophthalmic Res 2010, 44:191-198. 10.1159/000316476, 20829643.
52. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. Müller cells in the healthy and diseased retina. Progress in Retinal and Eye Research 2006, 25:397-424. 10.1016/j.preteyeres.2006.05.003, 16839797.